Costs of medicines and health care: a concern for Australian women across the ages by unknown
Walkom et al. BMC Health Services Research 2013, 13:484
http://www.biomedcentral.com/1472-6963/13/484RESEARCH ARTICLE Open AccessCosts of medicines and health care: a concern for
Australian women across the ages
Emily J Walkom1*, Deborah Loxton2 and Jane Robertson1Abstract
Background: Evidence from Australia and other countries suggests that some individuals struggle to meet the
costs of their health care, including medicines, despite the presence of Government subsidies for low-income
earners. The aim of our study was to elucidate women’s experiences with the day to day expenses that relate to
medicines and their health care.
Methods: The Australian Longitudinal Study on Women’s Health (ALSWH) conducts regular surveys of women in
three age cohorts (born 1973–78, 1946–51, and 1921–26). Our data were obtained from free text comments
included in surveys 1 to 5 for each cohort. All comments were scanned for mentions of attitudes, beliefs and
behaviours around the costs of medicines and health care. Relevant comments were coded by category and
themes identified.
Results: Over 150,000 responses were received to the surveys, and 42,305 (27%) of these responses included
free-text comments; 379 were relevant to medicines and health care costs (from 319 individuals). Three broad
themes were identified: costs of medicines (33% of relevant comments), doctor visits (49%), and complementary
medicines (13%). Age-specific issues with medicine costs included contraceptive medicines (1973–78 cohort),
hormone replacement therapy (1946–51 cohort) and osteoporosis medications (1921–26 cohort). Concerns about
doctor visits mostly related to reduced (or no) access to bulk-billed medical services, where there are no out-of-
pocket costs to the patient, and costs of specialist services. Some women in the 1973–78 and 1946–51 cohorts
reported ‘too much income’ to qualify for government health benefits, but not enough to pay for visits to the
doctor. In some cases, care and medicines were avoided because of the costs. Personal feelings of embarrassment
over financial positions and judgments about bulk-billing practices (‘good ones don’t bulk-bill’) were barriers to
service use, as were travel expenses for rural women.
Conclusions: For some individuals, difficulty in accessing bulk-billing services and increasing out-of-pocket costs in
Australia limit affordability of health services, including medications. At greatest risk may be those falling below
thresholds for subsidised care such as self-funded retirees and those on low-middle incomes, in addition to those
on very low incomes, who may find even small co-payments difficult to manage.
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There is mounting evidence of the struggle for some
individuals and families to meet the costs of health care,
including medicines. In a Commonwealth Fund survey
of seven countries, 37% of US participants and 26% of
Australian participants reported either not filling a pre-
scription or skipping a dose, not visiting the doctor, or
missing medical tests, treatments, or follow-up because of
cost in the previous 12 months (greater than in Germany,
New Zealand, Canada, the UK and the Netherlands) [1,2].
Similar behaviours have been reported in other surveys of
Australian and US patients [3,4].
In Australia, the publicly funded Pharmaceutical Bene-
fits Scheme (PBS) aims to provide universally affordable
access to prescription medicines. All patients contribute
to the cost of their PBS medicines via taxation and graded
co-payments. There are two categories of patients, general
beneficiaries (who paid up to AU$35.40 per prescription
item in 2012) and concession or health care card holders
(including senior citizens and those in receipt of social
security support, who paid reduced contributions of AU
$5.80 per prescription item in 2012) [5]. Medical services
are available to all Australian citizens under the national
insurance scheme, Medicare, which covers all service costs
for doctors who ‘bulk-bill’. Bulk-billing doctors do not
charge the patient an additional fee, and accept the
Medicare rebate as full payment for the consultation [6].
Patients may pay additional out-of-pocket amounts for
doctors who do not bulk-bill (i.e. who charge more than
the agreed schedule fee) [7].
Even with this universal health insurance coverage
through Medicare and Government subsidised pres-
cription costs, out-of-pocket costs for medical care in
Australia are increasing [8]. Patient expenditure on all
prescription medicines increased from an average of
approximately 0.1% of household consumption expend-
iture in 1971 to 0.43% in 2007 [9]. Increases in patient
co-payments for medicines and visits to medical practi-
tioners have increased the financial burden on individ-
uals in recent years [10], especially for visits to specialist
practitioners [11]. Expenditure on complementary and
alternative medicines (CAM) in Australia is also in-
creasing, and was estimated at over AUD$4 billion in
2005 [12]. The costs of CAM are not subsidised by
Government, and use is skewed towards individuals
with higher household incomes [13], and with private
health insurance [12].
Particularly vulnerable to increases in out-of-pocket
medical expenses are those with chronic illness [2,8,14],
and those with comorbidities or who use multiple medi-
cations [15]. Heisler et al. [16] reported that women
were more likely than men to underuse medicines due
to costs. Kemp et al. [17] reported that medicines under-
use due to costs in Australia was significantly higher inyounger (18–29 year olds) and mid-aged people (30–
64 years), compared to those aged 65 and older; which is
understandable given that older Australians are entitled
to greater Government subsidies for their medicines.
However, other studies have reported that the financial
burden for older Australians is still high, despite access
to these subsidies [18]. Government concessions on
health care costs for those on low incomes do not
entirely protect individuals from out-of-pocket burden
or financial hardship [10,14]. Jeon et al. [15] and Doran
et al. [3] suggest that there may be a subgroup of
patients who are particularly vulnerable to increasing
health care costs: those who earn too much to qualify
for government subsidies, yet not enough to afford the
out-of-pocket costs of their medicines or doctor’s visits.
There are few qualitative studies in the Australian
setting that capture the attitudes and experiences of
individuals regarding the costs of medicines and health
care. One investigation of financial pressures due to ill-
ness involved interviews of patients with chronic illness
and their carers [15]. High out-of-pocket costs incurred
in the treatment of chronic illness were a concern for
many participants, including the cost of medicines,
consultations with general practitioners and specialists,
diagnostic tests, and transportation or parking costs.
Participants who were eligible for government subsidised
medications expressed gratitude for the scheme (the PBS),
stating that they would not otherwise be able to afford
their medicines. Another interview study reported that
although costs might delay a visit to the doctor until abso-
lutely necessary, the expenses involved with the visit and
with any prescribed medicines were not a concern for the
majority of the participants [3].
The present study investigates concerns about medi-
cines costs in three age cohorts of women taking part in
the Australian Longitudinal Study on Women’s Health
(ALSWH). Qualitative comments collected as part of
this study provide a rich source of information on topics
pertinent to the respondents, and thus offer a patient-
centred insight into the concerns and attitudes of women
regarding their health and well-being. Byles et al. [19]
reported on quantitative aspects of the use and costs of
medicines and other health care resources for women in
the ALSWH, and illustrated their findings with selected
comments from survey respondents. We wished to exam-
ine these free-text comments systematically and in greater
detail with the aim of the study to elucidate women’s
experiences with the day to day expenses that relate to
medicines and their health care.
Methods
Data for this study were drawn from the Australian
Longitudinal Study on Women’s Health (ALSWH). The
ALSWH is an ongoing survey of health and health
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three nationally representative age cohorts (named by
year of birth: 1973–78 cohort, 1946–51 cohort and
1921–26 cohort). These women were randomly selected
from the Medicare Australia database in 1996, and have
been followed up by mail surveys occurring on a three
yearly staggered cycle by age cohort. Surveys included in
this study commenced in 1996 and continued until
2009. The cohorts were intentionally oversampled for
those living in rural and remote areas. Detailed methods
of the ALSWH are available elsewhere [20]. The ALSWH
received ethical approval from the University of Newcastle
Ethics Committee (approval number: H-076-0795) and
the University of Queensland Medical Research Ethics
Committee (approval number: 200400224). While the
surveys do contain questions about the costs of visits to
the doctor and private health insurance, there are no items
that directly address the cost of medications.
Our data were obtained from free text comments
returned with the first five surveys for each of the three
age cohorts. At the end of each of the ALSWH surveys,
participants were asked, “Have we missed anything? If
there is anything else you would like to tell us, please
write on the lines below”. The comments are not
prompted by questions, allowing women to comment on
any aspect of their health or wellbeing. We scanned all
these comments for any mention of attitudes, beliefs and
behaviours around the costs of medicines and health
care. Following methods used in previous studies [21],
an inductive approach was taken for analysis. The
comments from each survey were reviewed by two
researchers (EW, JR) and code names were assigned to
relevant phrases, sentences or passages. Similar codes
were grouped by category, and a reflective process was
used to identify themes within the categories, with
comments reviewed several times to ensure consistency
in coding. Selected (de-identified) comments are pre-
sented to illustrate the views of the women and are
labelled by cohort (Y, M, O for 1973–78 [younger],
1946–51 [mid-aged] and 1921–26 [older] cohorts respect-
ively, and by survey number 1–5) with minor typograph-
ical and spelling errors corrected for ease of reading.Table 1 Number of comments from surveys of each age coho
1973-1978 responses 194
Survey Comments/Total % Commen
1 2423/14762 16.4 2447/
2 1948/9688 20.1 2058/
3 2267/9081 25.0 2672/
4 2056/9145 22.5 2966/
5 2415/8200 29.5 2915/
TOTAL 11109/50876 21.8 13058/Results
Comments
Over 150,000 responses were received to the five surveys
of each of the three age cohorts, and 42,305 (27%) of these
responses included free-text comments. The 1973–78,
1946–51 and 1921–26 cohorts provided 26%, 31% and
43% of these comments respectively (Table 1). Topics
covered by the comments were wide-ranging, but women
in all age cohorts commented on their personal health is-
sues, consultations with medical practitioners, preference
(or otherwise) for female doctors, attitudes towards taking
medications in general, adverse effects of some medicines,
and difficulties in accessing health care services, particu-
larly in regional and rural areas. Age-specific issues with
medications were also reported, for example: contracep-
tive medicines for the 1973–78 cohort, hormone replace-
ment therapy for the 1946–51 cohort and osteoporosis
medications for the 1921–26 cohort. Some women com-
mented that the ALSWH surveys did not directly address
the issue of health care costs.
Of the 42,305 comments, 379 were identified as cover-
ing topics that related to the research questions and
were included in the current analysis, 28% from the
1973–78 cohort, 50% from the 1946–51 cohort and 22%
from the 1921–26 cohort. The included comments were
from 319 individuals, with some women making relevant
comments in more than one survey.
Most of the survey comments considered by the
researchers to contain remarks relevant to costs of
medicines and related health care could be divided into
three broad themes: doctor visits (49% of relevant com-
ments), medicines (33%), and complementary medicines
(13%, Table 2). Women from the 1946–51 cohort were
more likely to comment on health care costs than those
in the 1973–78 and 1921–26 cohorts.
Costs of doctor visits
Women from all age cohorts raised concerns with the
reduction or lack of bulk-billing (no out-of-pocket cost
to patient) medical services in their area. “No doctors in
[large rural town] bulk-bill, the ones who do are full”
(Y5); “Over the last 12 months two local practices havert
6-1951 responses 1921-1926 responses
ts/Total % Comments/Total %
14072 17.4 2978/12804 23.3
12338 16.7 4695/10434 45.0
11226 23.8 3955/8647 45.7
10905 27.2 3573/7158 49.9
10638 27.4 2937/5560 52.8
59179 22.1 18138/44603 40.7
Table 2 Number of comments relevant to costs of medicines and health care
Cohort Total Medicines N (%) Doctor visits N (%) Complementary medicines N (%) Other N (%)
1973-78 106 22 (20.8%) 72 (67.9%) 10 (9.4%) 2 (1.9%)
1946-51 188 53 (28.2%) 85 (45.2%) 30 (16%) 20 (10.6%)
1921-26 85 49 (57.6%) 27 (31.8%) 8 (9.4%) 1 (1.2%)
Total 379 124 (32.7%) 184 (48.5%) 48 (12.7%) 23 (6.1%)
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doctor that bulk-bills and I object to paying a $17 gap
for just a prescription and almost no consultation” (M3).
Conversely, other participants chose to deliberately avoid
bulk-billing doctors, reporting concerns with the percei-
ved quality of care from bulk-billing practices, particu-
larly large medical centres. “If you want a reasonable GP
you have to pay extra as the good ones don’t bulk-bill.
The ones that do bulk-bill treat you like cattle…” (Y2).
Difficulties in affording visits to non-bulk-billing doc-
tors were mentioned by all age groups: respondents from
the 1973–78 cohort (particularly students) mentioned
lack of income and government support as barriers to
access: “No Austudy [student welfare payment] (or any
other form of government support), therefore no money
available to see doctors and such unless it is a dire
emergency” (Y1). The 1921–26 cohort referred to their
pensioner status as a reason for being unable to afford
doctor visits: “Small country town medical clinics do not
give bulk-billing to aged pensioners and insist on cash
payment on the day of visit.… Many pensioners would
not seek medical help when needed if at the time no cash
was available” (O1). “This last 6 months money has be-
come a little tight as we are both attending the Dr quite
regularly and with the clinic we attend not bulk-billing
we are required to pay $3.50 per visit… the extra cost per
week in the last 2 or 3 months has been approximately
$15-$20; this sure makes a hole in the pension…” (O1).
“Charges for re-writing scripts are expensive, at least $3
to $5, this is not claimable” (O3). The added burden of
claiming a partial refund from Medicare for each non-
bulk-billed consultation was mentioned by some of the
1921–26 cohort: “… I don’t like to complain, please for-
give me, but since bulk-billing and increase in lots of chem-
ist prices, it is more difficult. We now have to make extra
trip to Medicare to collect some of the fee back” (O3).
In the 1946–51 cohort, women mentioned embarrass-
ment over their financial position, and the inability to
claim back money spent on visits to the doctor. “Reasons
for not asking professional help for many minor ailments
are cost and time of transport to services and also cost of
medication etc. - if possible I keep away from doctors,
dentists etc. because of cost and subsequent embarrass-
ment because of my poor financial position” (M2). “I
intend to put up with minor complaints and not visit thedoctor mainly because I have to pay for my visit and am
unable to get back the gap even though I have private
health cover.” (M1). “I feel that a lot of women ignore
their health due to financial circumstances. When you
are a low income earner and have to save to visit a
doctor, it certainly makes life difficult. If all doctors
bulk-billed it would make it easier or at least let you
claim on Medicare and then pay the difference in-
stead of demanding payment in advance. For myself I
would like to go and have a full check-up but it is
financially impossible” (M1).
Some women in the 1973–78 and 1946–51 cohorts
reported earning ‘too much income’ to qualify for gov-
ernment health benefits, but not enough to pay for visits
to the doctor: “…we earn too much apparently to have a
heath care card, but we don’t earn a lot to afford to pay
to see a doctor. … The government has no idea what kind
of pressures this puts on mothers” (Y3). “… Although I
earn just over 11 dollars per hour I am not eligible for a
health care card so I’m precluded from pap smears and
other medical services” (M2). “Because of our assets I am
not entitled to any form of assistance but each week the
cost of my medications, doctor’s visits, tests and X-ray do
not help our cash situation” (M4).
Comments from the 1946–51 and 1921–26 cohorts
mentioned the specific difficulties faced by self-funded
retirees. “My husband and I are self-funded retirees. We
have saved and forgone holidays over many years to
avoid the need for a pension, and lower interest rates
now affect our income. Many people in our situation
avoid seeking medical attention even when it would
be advisable, because of the big difference in the
“excess of the prescribed fee” that the doctors charge -
and this also for specialists, radiographers, etc. that
may follow on. This means that free Medicare is a
myth” (O1).
Women of all ages in regional and rural areas reported
not only increased difficulty in accessing necessary
health care services in their area, but also increased
costs associated with travel and overnight stays, when
health care services were located far away from their
homes. “… I saw a specialist and had [tests] at a base
hospital. In the days of bulk-billing (alas, no more) this
service was free, but the last two episodes have cost
$40 apiece. This together with cost of petrol to travel
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treatment” (O3).
Some respondents had difficulties affording the cumu-
lative costs of attending a doctor to obtain a prescription
then buying the medicine: “… We have great problems
being able to afford 30–70 dollar doctor’s fees even if you
can claim it back. We have to rush around to Medicare
to get it back so we can get through the week. … We then
have to weigh up if we can afford any prescribed medi-
cines” (Y1). “… Some weeks I don’t have a spare $40 to
see a doctor and another $20 or so to buy medicine. This
has caused me some stress and concern over my health
in the last 12 months” (Y3).
Costs of medicines
Women of all ages mentioned the costs of prescription
medicines in their comments. The specific topics covered
differed for each of the age cohorts surveyed.
Many of the comments from the 1973–78 cohort
relating to the costs of medicines concerned the cost of
the contraceptive pill, whether used for contraceptive
purposes or for management of other conditions: “…the
reason I am not taking the pill right now is I don’t want
to pay to go to the GP or for the pills” (Y3). “Currently
not on the pill as the one I take (for contraception and
other health reasons) is too expensive” (Y3). Some youn-
ger respondents mentioned other particular medicines:
“Annoyed that medicines that would help me (if they
work they put the prices up!) are so expensive - Arthritis
medicine, Flu shots and even Cold Sore Cream!” (Y2).
One respondent from the 1973–78 cohort wrote of her
reliance on government-subsidised prescriptions: “I
rely heavily on those government scripts. They are
great otherwise I would be at the chemist every
2 weeks. I get 4 packets at once. It’s all authorised
through my doctor. It would also cost me a fortune if
I wasn’t on a health care card. I don’t know how those who
aren’t cope” (Y3).
Women in the 1946–51 cohort mentioned the on-going
cost of medications for chronic illnesses: “… Frustratingly
most of the problems I encounter require medication for
life. No condition is really in and of itself, life threatening
but all are a reminder of an ageing body. Current medica-
tions cost approx. $190 or more per month” (M3). “…Pre-
scriptions (e.g. eye drops, which I have to use twice daily
for the rest of my life) should be less expensive if a woman
has to use something on a long term basis.” (M1). “Having
experienced epilepsy for 35 years - … My drugs cost over
$60 per month. As my husband is in work we have no
health care card” (M1). “I feel it is important you know
that being single on a low income with no other support,
buying my home … I cannot afford to pay for all my scripts
for asthma and allergy … So if I neglect my health it is
purely because of financial difficulty” (M2).In the later surveys of the 1946–51 cohort, the
issue of non-subsidised osteoporosis medication was
raised: “Osteoporosis – on-going medication and screening
very expensive if not entitled to health care card and
finance Private Health Insurance - Essential HRT and
some medication not on PBS e.g. [Medicine name] very
expensive if not entitled to Health [Care] Card” (M4). “....
My bone is worse I need [Medicine name] but I can’t afford
to pay $68 a month for 4 tablets.” (M5). Other non-
subsidised medicines were also mentioned: “… I have
started treatment with [skin cancer cream]. … is not on the
“pharmaceutical list”. I am a d.s [disability support] pen-
sioner total income $175 per week the 3 tubes of cream cost
$132, so I couldn’t buy food” (M2). “… I also use cheaper
medication (for migraine) because the cost of the better
medication is prohibitive ($60 for 2 tablets) and there is a
limit to the pharmaceutical benefits I can claim in a
12 month period” (M1).
Hormone replacement therapy was a hot topic for
women in the 1946–51 cohort, but most comments con-
cerned side effects, or the choice between prescription
hormone replacement therapy and alternative treatment
methods. A few women did raise issues around the costs
of treatment: “… I think the price of HRT is high as it is
not an optional medicine it is a necessity” (M2).
For women in the 1921–26 cohort, the high cost of
medicines in general was an issue for both self-funded
retirees and for women receiving a pension. Some
women were unhappy that their income precluded them
from receiving a Health Care Concession Card, which
reduces the cost of subsidised prescription medicines. “I
feel dissatisfied with attitude of Health Department in
dealing with self-funded retirees. I earn just too much to
get a Commonwealth Health Card through thrifty living
and wise investment, but have high on-going medication
expenses” (O1).
Even with concessions on medication prices, it was
still too much to pay for some women. “I would like to
see all pensioners get free medicine, jabs etc. free instead
the safety net as once you have $140.00 you get it free.
But until you make the $140.00 it is a struggle … I need
more than two scripts a fortnight so I have to pay the
extra which gives you a choice of you have medication or
food” (O1).
Some medications are not eligible for any subsidy or
government concessions: “… having to pay extra for
medication because generic brands do not help to keep
severe [condition] … under control. The [medication
name] … the most controllable medication I have used.
My problem is that they used to cost me $2.70 and now
have jumped to $12.35. Plus other medications go up in
price quite often. I get a pension rise and the government
take it back and more this way” (O1). “The doctor put me
on a capsule called [medication name]. These capsules
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they only last fifty days. The government does not help
with the cost of these which makes it very expensive.”
(O2). “I have to be in hospital when I get [type of infec-
tion] which requires intravenous antibiotics. Some of
them are very expensive which I take home orally, one is
$200 the other is $90 = $290 per month, that is more
than one week’s pension, without help from my daughter,
I would not be able to have these drugs” (O3).
As with the 1946–51 cohort, the older women also
mentioned the cost of non-subsidised osteoporosis
medications. “I have to pay full price for tab [Medicine
name]. I haven’t had a break or bone fracture, only pain
from past injuries. I wonder why this medication can’t be
available to patients over a certain age, before they do
have a break or fracture to bones filling up the hospitals
and nursing homes. It could be cheaper for the govern-
ment in the long run” (O4) “… I went on to a new treat-
ment called [name]. The specialist thinks well of this
18 month treatment and it seems to be working, but it is
expensive (total cost over 18 months $15,000) and is not
on the pharmaceutical benefits, so if you can’t pay, too
bad” (O5). “I was prescribed [Medicine name] quite a
long while ago but due to the scare about it having bad
side effects such as gum infection I was taken off it by my
doctor. There is no medication prescribed under the
PBS scheme for osteoporosis even though it is life
threatening” (O5).
Costs of complementary medicines
Women in the 1946–51 cohort were more likely than
women in the 1921–26 or 1973–78 cohorts to mention
issues with the cost of complementary medicines in their
comments. Few younger women had comments in this
area. Respondents expressed a desire for the costs of
complementary medicines to be government subsidised:
“…It is frustrating that medical funds do not refund as
much for “alternative” treatments which in some cases
are most effective” (M1). “… The cost of natural sup-
plements such as herbs, vitamins minerals, should be
covered by health funds or government assistance. It costs
me about $150 per month for natural supplements, on
which ability to earn a living depends.” (M2). “… Naturo-
path understanding and trying to help - but it’s difficult
for one on limited income, as I can’t use my Health Care
Card at Naturopath.” (M3). “Unfortunately vitamins etc.
are becoming almost as expensive as medication. They
should be subsidised to help older people afford them…”
(O2). “Is there any way herbal medicines can be put on
the pharmaceutical list?” (O2).
Discussion
While the majority of Australians appear to have reason-
able access to healthcare, our data show that difficultiesin accessing bulk-billing (no cost to patient) services and
increasing out-of-pocket costs have had a detrimental
impact on some women’s ability to afford health services,
including medications (see also Young and Dobson 2003
[6]). Based on comments from our survey, groups that
may be at particular risk, are those who just miss out on
thresholds for subsidised care (health care cards) such as
self-funded retirees and those on middle incomes, in
addition to those on very low incomes, such as students,
who meet threshold requirements but find even minimal
co-payments to be out of reach. Further research is
required to explore this further. Personal feelings of
embarrassment over their financial positions as well as
judgments about the value of bulk-billing practices were
also barriers to service use, as were travel expenses for
women living in non-urban areas.
Many of the aspects raised by the women were com-
mon to all age cohorts, while others were relevant to
each particular stage of life. Women in the 1946–51
cohort may be more likely to earn too much money to
qualify for financial assistance compared with younger
women, who may still be students, or older women, who
are more likely to receive the age pension and associated
concessions. Women from the 1946–51 cohort also men-
tioned the burden of medicines for long-term treatment
or chronic illness, supporting findings from previous
research [14,15]. Women from the 1946–51 and 1921–26
cohorts both mentioned the costs of osteoporosis treat-
ment, and the cumulative costs of multiple medications.
Almost half of the relevant comments made by partici-
pants concerned the costs of visits to medical practi-
tioners. Concerns were raised by women from all age
cohorts about the lack of access to fully-subsidised
consultations with medical practitioners (bulk-billing).
Substantial out-of-pocket expenses are incurred when
doctors charge more than the scheduled fee (which is
Government funded) – especially for those with multiple
comorbidities. Comments from the first three surveys of
each age cohort were from a time when bulk-billing
rates were at a historic low; media reports at the time
refer to rapid growth in out-of-pocket fees for patients
[22,23]. Government reforms to the Medicare system in
2003 introduced incentives to medical practitioners to
increase bulk billing rates, particularly in rural and
remote areas, as well as in metropolitan areas with lower
rates of bulk-billing [24]. Bulk-billing rates have been
increasing since these reforms to a high of around 81%
Australia-wide in March 2013 [25]. Bulk billing rates are
now higher in remote areas than in major cities.
Nevertheless, there were still comments in the surveys
conducted post-2003 reforms that indicate that lack of
access to bulk-billing doctors remains a concern for
some women. Furthermore, some women voiced a lack
of confidence in the quality of care received at bulk-
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ones that do bulk-bill treat you like cattle…”).
There are safety-nets which reduce or remove patient
co-payments once a certain level of out-of-pocket spend-
ing has been reached, but many households struggle
before they meet these minimum levels of spending [14].
As shown in previous research [14,18], women eligible
for a concession or pension card were not shielded from
the burden of high out-of-pocket healthcare costs. This
is a concern if women are facing difficulties with the
costs of health professional visits, as this is only the first
step in accessing prescription medicines.
The Australian health care system provides mecha-
nisms that go some way to protect the most vulnerable
against financial barriers to access – those on low inco-
mes, with social security support, and retired persons
more likely to have multiple comorbidities. But others
continue to struggle – the “working poor,” who despite
paid employment [26], find resources are strained trying
to meet out-of-pocket expenses, such as medical and
prescription costs [27]. As demonstrated in a number of
settings, the response for some is to avoid seeking care,
choosing not to get prescriptions dispensed, or not
taking medicines as directed [1-3], with poorer health
outcomes as a result [16]. Policies that increase patient
contributions and out-of-pocket expenses may be
consistent with ‘user pays’ principles that are designed to
encourage quality use of medicines and help Governments
meet their budgetary targets; however there can be unin-
tended consequences - along with compromised health
care and health outcomes, there is family stress and
anxiety as families make uncomfortable choices about
prioritising medical needs and choosing between food,
doctor visits and prescription medicines.
The use of complementary and alternative medicines
is growing [12]. There were many comments made by
participants in the ALSWH from all age cohorts regard-
ing perceptions of benefits and preference for CAM over
conventional prescription medicines (although these
were not examined in detail in this study), and some
women questioned why access to these medicines was
not subsidised by taxpayers. The cost of CAM has been
noted as a barrier to access in other studies of mid-aged
women during menopause [28]. A challenge for the
manufacturers of these medicines is to assemble the
clinical data to support claims of the cost-effectiveness
of CAM. Demonstration of cost-effectiveness is a pre-
requisite for listing on the Australian PBS [29].
There are some limitations with our data. Only a very
small minority of women in the ALSWH identified the
costs of medicines and health care as a concern, and cau-
tion is warranted in interpreting these comments as being
representative of the wider population. Nevertheless, there
were sufficient responses across all cohorts to indicatecost is an important consideration for some women and
across the ages. These comments were spontaneous; the
women were not directly asked to comment on health
care costs, and yet it was important enough for them to
write down and share their experiences with ALSWH
investigators. Health care costs were a problem despite
the existence of universal health insurance (Medicare) and
Government subsidises (concession cards for low income
earners and safety nets) designed to mitigate the costs of
medical consultations and prescription medicines for
Australian families.
Our sample consisted only of women. However,
women tend to make most of the health care decisions
for their family [30], and tend to be more frequent users
of health care services in general, particularly women of
childbearing age [31]. Women may have more frequent
contact with health care providers due to a greater
utilisation of preventive health care [32]. Although the
ALSWH respondents have generally been shown to be
broadly representative of the Australian population,
there is some response bias towards women with tertiary
education and under-representation of some groups of
immigrant women [33]. What this means for our data is
that cost concerns may be under-reported, if the sample
is skewed towards women who are likely to have higher
incomes. There has been some attrition in later surveys
of each age cohort; however the number of comments
has not reduced proportionally (Table 1). In addition,
withdrawal from the on-going surveys often relates to
being burdened with illness and other health and family
issues; those women may be more likely to be struggling
with health care costs. However, responses to the open-
ended invitation to comment on any aspect of health
may be biased toward the negative [34].
Some of the specific issues raised by participants in
the surveys, conducted between 1996 and 2009, may no
longer be concerns due to policy changes. For example,
members of the 1921–26 cohort mentioned the strict
restrictions on access to subsidised osteoporosis medica-
tions; these restrictions have since been relaxed and
more women are now able to access the medicines
through the PBS at a greatly reduced personal cost.
However, there are on-going concerns about access to
other new and often expensive medicines in the Australian
community. Studies on the impact of increased out-of-
pocket (co-payment) medicine costs suggest that the
increased costs negatively impact on use of common and
important chronic use medicines such as statins [35].
Conclusions
Australia’s healthcare system is designed to reduce fi-
nancial barriers to access, but there are still groups who
incur proportionally large out-of-pocket costs, particularly
those with multiple comorbidities and chronic conditions.
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ameliorate this burden. Our examination of comments
provided spontaneously from women of all age groups
show that these issues of affordability continue to be
reported over time and affect women of all ages.
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